New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer – What do we understand so far?
- Jean Hoffman-Censits
- , Kara Lombardo
- , David McConkey
- , Noah M. Hahn
- , Babar Bashir
- , Wm Kevin Kelly
- , Burles Johnson
- , Andres Matoso
Research output: Contribution to journal › Article › peer-review